{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:54:53Z","timestamp":1783508093889,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41409-025-02698-9","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T20:57:40Z","timestamp":1755550660000},"page":"1526-1528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term survival in patients with Philadelphia-chromosome-positive acute lymphoblastic leukemia who relapse after allogeneic hematopoietic stem cell transplantation: a single-center experience"],"prefix":"10.1038","volume":"60","author":[{"given":"Huan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0267-1081","authenticated-orcid":false,"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-6792","authenticated-orcid":false,"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1253-7465","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-9034","authenticated-orcid":false,"given":"Yi-fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9881-7945","authenticated-orcid":false,"given":"Xiao-Dong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-2231","authenticated-orcid":false,"given":"Yu-Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1548-0946","authenticated-orcid":false,"given":"Ya-Zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6124-6050","authenticated-orcid":false,"given":"Ying-Jun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"2698_CR1","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1002\/cncr.30130","volume":"122","author":"S Giebel","year":"2016","unstructured":"Giebel S, Czyz A, Ottmann O, Baron F, Brissot E, Ciceri F, et al. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer. 2016;122:2941\u201351. https:\/\/doi.org\/10.1002\/cncr.30130","journal-title":"Cancer"},{"key":"2698_CR2","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/ajh.25648","volume":"94","author":"IA Dalle","year":"2019","unstructured":"Dalle IA, Kantarjian HM, Short NJ, Konopleva M, Jain N, Garcia-Manero G, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors. Am J Hematol. 2019;94:1388\u201395. https:\/\/doi.org\/10.1002\/ajh.25648","journal-title":"Am J Hematol"},{"key":"2698_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41409-020-01173-x","volume":"56","author":"K Hirschb\u00fchl","year":"2021","unstructured":"Hirschb\u00fchl K, Labopin M, Houhou M, Gabellier L, Labussi\u00e8re-Wallet H, Lioure B, et al. Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplant. 2021;56:1190\u20139. https:\/\/doi.org\/10.1038\/s41409-020-01173-x","journal-title":"Bone Marrow Transplant"},{"key":"2698_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/ajh.26853","volume":"98","author":"I Aldoss","year":"2023","unstructured":"Aldoss I, Shah BD, Park JH, Muffly L, Logan AC, Brown P, et al. Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed\/refractory B-cell acute lymphoblastic leukemia. Am J Hematol. 2023;98:666\u201380. https:\/\/doi.org\/10.1002\/ajh.26853","journal-title":"Am J Hematol"},{"key":"2698_CR5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1158\/1078-0432.ccr-21-2675","volume":"28","author":"A Bazarbachi","year":"2022","unstructured":"Bazarbachi A, Labopin M, Aljurf M, Niittyvuopio R, Balsat M, Blaise D, et al. 20-year steady increase in survival of adult patients with relapsed Philadelphia-positive acute lymphoblastic leukemia post allogeneic hematopoietic cell transplantation. Clin Cancer Res. 2022;28:1004\u201312. https:\/\/doi.org\/10.1158\/1078-0432.ccr-21-2675","journal-title":"Clin Cancer Res"},{"key":"2698_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00277-010-1039-57","volume":"90","author":"Y Qin","year":"2011","unstructured":"Qin Y, Chen S, Jiang B, Jiang Q, Jiang H, Li J, et al. Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients. Ann Hematol. 2011;90:47\u201352. https:\/\/doi.org\/10.1007\/s00277-010-1039-57","journal-title":"Ann Hematol"},{"key":"2698_CR7","doi-asserted-by":"publisher","first-page":"1110e1116","DOI":"10.1016\/j.bbmt.2015.02.009","volume":"21","author":"H Chen","year":"2015","unstructured":"Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH, et al. Haploidentical Hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of Philadelphia Chromosome positive acute lymphoblastic leukemia. Biol Blood Marrow Transpl 2015;21:1110e1116.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2698_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106930","volume":"121","author":"H Chen","year":"2022","unstructured":"Chen H, Xu LP, Zhang XH, Wang Y, Chen YH, Yan CH, et al. Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutation. Leuk Res. 2022;121:106930. https:\/\/doi.org\/10.1016\/j.leukres.2022.106930","journal-title":"Leuk Res"},{"key":"2698_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1756-8722-5-29","volume":"5","author":"H Chen","year":"2012","unstructured":"Chen H, Liu KY, Xu LP, Liu DH, Chen YH, Zhao XY, et al. Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. J Hematol Oncol 2012;5:29.","journal-title":"J Hematol Oncol"},{"key":"2698_CR10","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1038\/leu.2017.145","volume":"31","author":"J Pan","year":"2017","unstructured":"Pan J, Yang JF, Deng BP, Zhao XJ, Zhang X, Lin YH, et al. High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients. Leukemia. 2017;31:2587\u201393. https:\/\/doi.org\/10.1038\/leu.2017.145","journal-title":"Leukemia"},{"key":"2698_CR11","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.24.00108","volume":"42","author":"R Kim","year":"2024","unstructured":"Kim R, Calandon Y, Rousellot P, Cayuela JM, Huguet F, Balsat M, et al. Significance of measurable residual disease in adult Philadelphia chromosome\u2013positive ALL: A GRAAPH-2014 Study. J Clin Oncol. 2024;42:3140\u201350.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02698-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:20:38Z","timestamp":1762183238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02698-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2698"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02698-9","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was reviewed and approved by the Ethics Committee of Peking University People\u2019s Hospital and was conducted in accordance with the Declaration of Helsinki. Patients or their legal guardians had provided written informed consent for the data collection and any subsequent analysis of data before the transplantation procedure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}